ADMA (Asymmetric Dimethylarginine)
Here’s what it reflects — and what to do about it.
Longetic pulls together every lab and record you’ve had, follows how ADMA (Asymmetric Dimethylarginine) changes over time, and explains what’s shifting — so you walk into your next appointment prepared, with reminders for retests along the way.
What is ADMA (Asymmetric Dimethylarginine)?
A small molecule made when the body breaks down certain proteins, and it can interfere with how blood vessels relax.
ADMA is a naturally occurring compound that can block the enzyme that helps your blood vessels make nitric oxide, a signal that lets them relax and widen. Higher levels have been associated in research with stiffer, less flexible blood vessels and with a greater long-term risk of heart and circulation problems, and levels also tend to rise when the kidneys are not clearing it well. This is an advanced, research-oriented marker that is not part of a routine blood panel.
What to know about ADMA (Asymmetric Dimethylarginine)
Understanding ADMA (Asymmetric Dimethylarginine) means knowing what it reflects, what tends to move it, and the signs that suggest it’s worth a closer look — so you can bring the right questions to your next appointment.
This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Medical Disclaimer.
References
About our sources
Official sources
Government health agencies, national institutes, and intergovernmental bodies whose guidelines carry regulatory or policy weight.
Clinical / professional
Medical societies, specialty colleges, and professional associations whose consensus statements reflect clinical practice standards.
Peer-reviewed research
Original research articles and systematic reviews published in indexed journals and verified through PubMed or DOI.